GLP-1 Pill Shows Benefit in Sleep Apnea

Summary
(MedPage Today) -- The oral GLP-1 receptor agonist orforglipron (Foundayo) improved sleep-disordered breathing in patients with moderate-to-severe obstructive sleep apnea and overweight or obesity, two phase III trials showed. For the treatment...
Description from Medpagetoday.
Who is covering this
-
GLP-1 Pill Shows Benefit in Sleep Apnea
(MedPage Today) -- The oral GLP-1 receptor agonist orforglipron (Foundayo) improved sleep-disordered breathing in patients with moderate-to-severe obstructive sleep apnea and overweight or obesity, two phase III trials showed. For the treatment...
Comments
Comments need JavaScript.